A new trading day began on Tuesday, with Laboratory Corp. Of America Holdings (NYSE: LH) stock price down -0.03% from the previous day of trading ,before settling in for the closing price of $210.12. LH’s price has ranged from $179.58 to $234.09 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 2.87% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 9.47%. With a float of $83.78 million, this company’s outstanding shares have now reached $83.90 million.
In an organization with 67000 employees, it is important to assess its efficiency.
Laboratory Corp. Of America Holdings (LH) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Laboratory Corp. Of America Holdings is 0.38%, while institutional ownership is 97.79%. The most recent insider transaction that took place on Apr 01 ’24, was worth 1,407,387. In this transaction EVP, Pres Diagnostics & COO of this company sold 6,477 shares at a rate of $217.29, taking the stock ownership to the 5,036 shares. Before that another transaction happened on Apr 01 ’24, when Company’s EVP, Chief Marketing Officer sold 3,500 for $217.29, making the entire transaction worth $760,515. This insider now owns 3,975 shares in total.
Laboratory Corp. Of America Holdings (LH) Latest Financial update
In its latest quarterly report, released on 12/30/2023, the company reported earnings of $3.3 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.82 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.32% during the next five years compared to -11.14% drop over the previous five years of trading.
Laboratory Corp. Of America Holdings (NYSE: LH) Trading Performance Indicators
Here are Laboratory Corp. Of America Holdings’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.37. Likewise, its price to free cash flow for the trailing twelve months is 20.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.65, a number that is poised to hit 3.49 in the next quarter and is forecasted to reach 16.11 in one year’s time.
Technical Analysis of Laboratory Corp. Of America Holdings (LH)
Let’s dig in a bit further. During the last 5-days, its volume was 0.61 million. That was inferior than the volume of 0.73 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 17.41%. Additionally, its Average True Range was 3.53.
During the past 100 days, Laboratory Corp. Of America Holdings’s (LH) raw stochastic average was set at 15.42%, which indicates a significant decrease from 22.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 13.95% in the past 14 days, which was lower than the 17.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $217.18, while its 200-day Moving Average is $213.17. However, in the short run, Laboratory Corp. Of America Holdings’s stock first resistance to watch stands at $211.82. Second resistance stands at $213.60. The third major resistance level sits at $214.51. If the price goes on to break the first support level at $209.14, it is likely to go to the next support level at $208.23. The third support level lies at $206.45 if the price breaches the second support level.
Laboratory Corp. Of America Holdings (NYSE: LH) Key Stats
With a market capitalization of 17.67 billion, the company has a total of 84,126K Shares Outstanding. Currently, annual sales are 12,162 M while annual income is 418,000 K. The company’s previous quarter sales were 2,293 M while its latest quarter income was -167,100 K.
